Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference
Mobia Medical (MOBI) management will participate in the 8th Annual Wolfe Research Healthcare Conference in New York on November 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Mobia Medical (MOBI) management will participate in the 8th Annual Wolfe Research Healthcare Conference in New York on November 10, 2026. The fireside chat is scheduled for 12:20 p.m. Pacific / 3:20 p.m. Eastern, and management will also host one-on-one investor meetings. Live and archived versions of the chat will be available on the company’s investor website under News & Events.
Details
News Market Reaction – MOBI
On Nov 4, the first trading day after this news, MOBI closed 12.74% above the previous close. Argus tracked a peak move of +8.2% during that session. Our momentum scanner recorded 16 alerts for this stock that day. That session’s volume was 2.5x the stock’s average daily volume.
Data tracked by StockTitan Argus for the Nov 4 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will participate in a fireside chat and host one-on-one investor meetings at the upcoming 8th Annual Wolfe Research Healthcare Conference in New York. The fireside chat will take place on Tuesday, November 10, 2026, at 12:20 p.m. Pacific Time / 3:20 p.m. Eastern Time.
Event: 8th Annual Wolfe Research Healthcare Conference
Date: Tuesday, November 10, 2026
Time: 12:20 p.m. PT / 3:20 p.m. ET
Webcast: https://event.summitcast.com/view/NUQKc6DhSdr7nD3Q2zrrqL/Y2MXruawnsXcnfxYAbBzJ6
A live and archived version of the fireside chat will be available via the News & Events page of the investor section of Mobia Medical’s website.
About Mobia Medical, Inc.
Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.
Investor Relations Contact
Louisa Smith
Gilmartin Group, LLC
investors@mobia.com
Media Inquiries Contact
Terri Clevenger
tclevenger@waterhousebrands.com
